 NEW YORK--BUSINESS WIRE-- classaction--The law firm of Kirby McInerney LLP is investigating potential claims against Myriad Genetics Inc. Myriad or the Company NASDAQ: MYGN. The investigation relates to possible breaches of fiduciary duty by certain officers and directors of the Company. In July 2019, the Company paid 9.1 million to resolve claims brought by a whistleblower that formed the basis for a subpoena issued by the U.S. Department of Health and Human Services Office of Inspector General t 